Charlottesville, VA, San Diego, CA, New York, NY and Paris, France (PRWEB) July 20, 2009
OpenQ, a leading provider of technology and information solutions for the life sciences industry announced today a continuing trend of profitable growth amidst global turmoil in the Life Sciences market. OpenQ posted a phenomenal 200% revenue growth in the first half of 2009 as compared to the same time last year. The exceptional first half results were driven primarily by new customer signings in the United States and Europe. OpenQ is now serving 7 of the Top 10 pharmaceutical and 3 of the Top 5 medical device companies.
The results of the first half continue the trend of rapid growth enjoyed by the company in 2008 and expected for the remainder of 2009.
"We are extremely pleased with these numbers and we believe that openQ products are increasingly becoming the critical components for life sciences companies in managing compliance, KOL relationships, IIS, speakers and content. As we continue to expand our product portfolio and build strong partnerships with our customers, we are poised for strong growth in the coming years," said Jim Zufoletti, openQ President.
"Our offerings bring to clients the best in class solutions for managing the growing challenges they are facing in the market. In the compliance space alone, openQ has introduced several innovative solutions and data products to meet the new market realities around supporting FMV, disclosure, aggregate spend, and spending caps. We have also continued our commitment to open standards and cloud computing through our products and the way we support our customers," said Otavio Freire, Executive Vice President of Technology.
OpenQ product launches, led by openQ, also included new releases for:
•Compliance and Management of Educational Grants and Investigator Initiated Trials
•Organization Profiling and Analytics
OpenQ provides award-winning insight and software solutions that allow Life Science companies to meet their most critical compliance, KOL, IIS, content and speaker needs from the earliest stages of development to maturity. Achieving another year of exponential growth, openQ serves its customers globally from various locations across North America, South America, Europe and Asia. OpenQ's growing list of customers includes 7 of the Top 10 pharmaceutical and 3 of the Top 5 medical device companies. For more information, visit http://www.openq.com.